Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Capital Expenditures (2023)

Historic Capital Expenditures for ADC Therapeutics (ADCT) over the last 1 years, with Q4 2023 value amounting to $327000.0.

  • ADC Therapeutics' Capital Expenditures changed N/A to $327000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $867000.0 for FY2024, which is 7304.1% down from last year.
  • Latest data reveals that ADC Therapeutics reported Capital Expenditures of $327000.0 as of Q4 2023.
  • ADC Therapeutics' 5-year Capital Expenditures high stood at $1.2 million for Q2 2023, and its period low was $327000.0 during Q4 2023.